. Author manuscript; available in PMC: 2011 Aug 1.

Published in final edited form as: Bone Marrow Transplant. 2010 May 17;46(2):300–307. doi: 10.1038/bmt.2010.112

Table 3.

Multivariable analysis of cause-specific hazard ratios for the acquisition of acute graft versus host disease grade 2 or higher

Risk Factor	Possible Endpoints (Competing Risks)
	Acute GVHD Grade 2 or Higher			All-Cause Mortality
	CSHR	95% CI	P value	CSHR	95% CI	P value
CMV seropositivity	0.45	0.25, 0.81	0.008	1.18	0.59, 2.36	0.64
Time to early BSI	2.17	1.05, 4.49	0.04	2.80	1.12, 6.53	0.02
Prior HSCT	0.50	0.20, 1.27	0.15	2.22	1.08, 4.54	0.03
etoposide	0.39	0.12, 1.26	0.12	2.80	1.36, 5.76	0.005

Analysis represents 199 patients with complete data sets.